HTN1: A Promising Drug Target and Biomarker for Cancer Research

Target Name: HTN1

NCBI ID: G3346

HTN1: A Promising Drug Target and Biomarker for Cancer Research

HTN1, also known as His1 protein, is a key regulator of the cell cycle and has been identified as a potential drug target in the field of cancer. The protein is involved in the metaphase of cell division and has been shown to promote the growth and survival of cancer cells.

Research has shown that HTN1 is often overexpressed in various types of cancer, including breast, lung, and ovarian cancer. This overexpression is associated with poor prognosis and increased risk of recurrence.

Additionally, HTN1 has been shown to contribute to the development and progression of various types of cancer. For example, studies have shown that HTN1 is overexpressed in various types of cancer, including breast, lung, and ovarian cancer, and that this overexpression is associated with the growth and survival of cancer cells.

Despite these findings, much work remains to be done in order to fully understand the role of HTN1 in cancer development and progression. One potential approach to studying HTN1 is to use it as a drug target. By targeting HTN1 with small molecules or other compounds, researchers may be able to inhibit its overexpression and reduce the growth and survival of cancer cells.

Another approach to studying HTN1 is to use it as a biomarker. By analyzing the expression of HTN1 in various types of cancer cells, researchers may be able to identify new biomarkers for the disease and develop new diagnostic tests.

In addition to its potential as a drug target and biomarker, HTN1 is also of interest to researchers due to its role in the regulation of the cell cycle. The protein is involved in the metaphase of cell division and has been shown to promote the growth and survival of cancer cells.

Understanding the regulation of the cell cycle is crucial for the development of new cancer therapies. HTN1's role in this process makes it an attractive target for researchers to study and may lead to the development of new treatments for cancer.

Overall, HTN1 is a promising drug target and biomarker for cancer research. Further studies are needed to fully understand its role in the regulation of the cell cycle and its potential as a therapeutic target.

Protein Name: Histatin 1

Functions: Histatins are salivary proteins that are considered to be major precursors of the protective proteinaceous structure on tooth surfaces (enamel pellicle). In addition, histatins exhibit antibacterial and antifungal activities

More Common Targets